Simplified equation to extract diffusion coefficients from confocal FRAP data M Kang, CA Day, AK Kenworthy, E DiBenedetto Traffic 13 (12), 1589-1600, 2012 | 264 | 2012 |
Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism RP Mason, MF Walter, CA Day, RF Jacob Journal of biological chemistry 281 (14), 9337-9345, 2006 | 214 | 2006 |
Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions RP Mason, MF Walter, CA Day, RF Jacob The American journal of cardiology 96 (5), 11-23, 2005 | 198 | 2005 |
Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction RP Mason, R Kubant, G Heeba, RF Jacob, CA Day, YS Medlin, ... Pharmaceutical research 25, 1798-1806, 2008 | 169 | 2008 |
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs MF Walter, RF Jacob, CA Day, R Dahlborg, Y Weng, RP Mason Atherosclerosis 177 (2), 235-243, 2004 | 153 | 2004 |
Tracking microdomain dynamics in cell membranes CA Day, AK Kenworthy Biochimica et Biophysica Acta (BBA)-Biomembranes 1788 (1), 245-253, 2009 | 148 | 2009 |
A generalization of theory for two-dimensional fluorescence recovery after photobleaching applicable to confocal laser scanning microscopes M Kang, CA Day, K Drake, AK Kenworthy, E DiBenedetto Biophysical journal 97 (5), 1501-1511, 2009 | 116 | 2009 |
Analysis of protein and lipid dynamics using confocal fluorescence recovery after photobleaching (FRAP) CA Day, LJ Kraft, M Kang, AK Kenworthy Current protocols in cytometry 62 (1), 2.19. 1-2.19. 29, 2012 | 109 | 2012 |
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity RP Mason, MF Walter, HP McNulty, SF Lockwood, J Byun, CA Day, ... Journal of Cardiovascular Pharmacology 47, S7-S14, 2006 | 104 | 2006 |
Intermolecular differences for HMG-CoA reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions RP Mason, MF Walter, CA Day, RF Jacob Am. J Cardiol 96 (5A), 11F-23F, 2005 | 99 | 2005 |
Chromosome missegregation during anaphase triggers p53 cell cycle arrest through histone H3. 3 Ser31 phosphorylation EH Hinchcliffe, CA Day, KB Karanjeet, S Fadness, A Langfald, ... Nature cell biology 18 (6), 668-675, 2016 | 92 | 2016 |
Functions of cholera toxin B-subunit as a raft cross-linker CA Day, AK Kenworthy Essays in biochemistry 57, 135-145, 2015 | 79 | 2015 |
A quantitative approach to analyze binding diffusion kinetics by confocal FRAP M Kang, CA Day, E DiBenedetto, AK Kenworthy Biophysical journal 99 (9), 2737-2747, 2010 | 78 | 2010 |
Mechanisms underlying the confined diffusion of cholera toxin B-subunit in intact cell membranes CA Day, AK Kenworthy PloS one 7 (4), e34923, 2012 | 63 | 2012 |
Microtubule Motors Power Plasma Membrane Tubulation in Clathrin‐Independent Endocytosis CA Day, NW Baetz, CA Copeland, LJ Kraft, B Han, A Tiwari, KR Drake, ... Traffic 16 (6), 572-590, 2015 | 62 | 2015 |
Lysosomal degradation ensures accurate chromosomal segregation to prevent chromosomal instability E Almacellas, J Pelletier, C Day, S Ambrosio, A Tauler, C Mauvezin Autophagy 17 (3), 796-813, 2021 | 35 | 2021 |
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAids RP Mason, MF Walter, CA Day, RF Jacob Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy …, 2007 | 34 | 2007 |
Topologically diverse human membrane proteins partition to liquid-disordered domains in phase-separated lipid vesicles JP Schlebach, PJ Barrett, CA Day, JH Kim, AK Kenworthy, CR Sanders Biochemistry 55 (7), 985-988, 2016 | 23 | 2016 |
Engineered disulfide bond greatly increases specific activity of recombinant murine interferon-β C DAY, B SCHWARTZ, BL Li, S PESTKA Journal of interferon research 12 (2), 139-143, 1992 | 21 | 1992 |
Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin CA Day, ML Marceau-Day, DF Day Antimicrobial agents and chemotherapy 37 (11), 2506-2508, 1993 | 19 | 1993 |